MS & Me Media for patients by patients. Visit our website https://teapawt.net/t.co/hCtcEKrQ5G, YouTube, or Facebook https://teapawt.net/t.co/wMMaWxdtRO
United States
Joined November 2016
- Tweets14.3K
- Following1.1K
- Followers838
- Likes3.8K
Pinned Tweet
People who do not have multiple sclerosis can never fully understand what it is like living with MS. What they can show us is empathy. MS & Me Media presents: Empathy #MSAwareness #WeHaveMS @MSPurposeRadio youtu.be/SQIYJ_BTmag
Study Finds High Dose Vitamin D Does Not Reduce Disease Activity in people with Relapsing-Remitting (RR) MS
abstractsonline.com/pp8/#!/1… @ACTRIMS
MSandMeMedia retweeted
MS Focus is hosting a virtual Q&A event led by Aaron Boster, MD, on Tues., Nov. 22nd, at 6:30 pm EST.
@AaronBosterMD is a board-certified Neurologist specializing in MS, making him the perfect person to answer your MS-related questions!
Pre-register now: msfocus.us/Boster1122
MSandMeMedia retweeted
#Remylenation in #MS. Dr Brown shares about current #research and timescales and how to get involved
youtu.be/YMQayl_-xAs
MSandMeMedia retweeted
Every time you have a lesion in a nerve pathway, surviving nerves are required to compensate for the damage 🧠
Discover more about MS progression and the best known ways to prevent it, featuring @tripping_onair and @GavinGiovannoni 👉 bit.ly/MSProgression_YT
#MultipleSclerosis
MSandMeMedia retweeted
This study from Oklahoma City Veterans Affairs of 279 PwMS showed that taking medication consistently was associated with lower mortality. "In the good adherence group, patients lived for a median of 52 years [after diagnosis]" Confounded data? multiplesclerosisnewstoday.c…
MSandMeMedia retweeted
Part of having strength is knowing that you can’t be strong all the time. Living with MS is hard. We can fake smiles and push through the pain, but sometimes we break…and that’s OK. We’re only human.
MSandMeMedia retweeted
monoclonal antibodies are effective for covid-19 in people taking b-cell depleters (ocrevus, rituximab, kesimpta) based on this observational study (5% of those treated hospitalized vs. 39.2% of those untreated hospitalized per this observational study) pubmed.ncbi.nlm.nih.gov/3579…
MSandMeMedia retweeted
Could EBV vaccines prevent MS in the future? An opinion article. Authors include @GavinGiovannoni and @AlbertoAscherio frontiersin.org/articles/10.…
MSandMeMedia retweeted
Does Ocrelizumab Limit Multiple Sclerosis Progression? Current Evidence from Clinical, MRI, and Fluid Biomarkers - PubMed pubmed.ncbi.nlm.nih.gov/3566…
MSandMeMedia retweeted
Tixagevimab and Cilgavimab (Evusheld) is an option for people with MS taking b-cell depleters (kesimpta/ocrevus/rituximab) who have a poor antibody response to covid-19 vaccines (image is pre and post antibody titers). pubmed.ncbi.nlm.nih.gov/3566…
MSandMeMedia retweeted
Aging & MS:New MS Living Well podcast
Drs. Weinstock-Guttman & Corboy on #aging well, immune changes & stopping MS meds DMTs.
bit.ly/38yZVQK🍎apple.co/3E1YAOd
@MS_Stumbling @TheMSKittylady @pettigrew66 @MarkWebb_ @DanJenDig @TwoFacesofMS @GenaMSwarrior @themsguide
MSandMeMedia retweeted
Measuring treatment response to advance precision medicine for multiple sclerosis - PubMed pubmed.ncbi.nlm.nih.gov/3470…
MSandMeMedia retweeted
The availability of 15 subsidised DMTs in Australia has transformed the quality of life of people with MS. 💊
Unfortunately, this is not the case for New Zealanders with MS, who only have access to four DMTs.
Read more 👉 ow.ly/oujO50GuiUw
#MS #RealMSResearch #VoiceForMS
MSandMeMedia retweeted
Safety of Ocrelizumab in Patients With Relapsing and Primary Progressive Multiple Sclerosis - PubMed pubmed.ncbi.nlm.nih.gov/3447…